User menu

IL-27p28 is essential for parent-to-F1 acute graft-versus-host disease.

Bibliographic reference Marillier, Reece G ; Uyttenhove, Catherine ; Goriely, Stanislas ; Marbaix, Etienne ; Van Snick, Jacques. IL-27p28 is essential for parent-to-F1 acute graft-versus-host disease.. In: European Journal of Immunology, Vol. 44, no. 7, p. 2064-2073 (2014)
Permanent URL http://hdl.handle.net/2078.1/142407
  1. Pflanz Stefan, Timans Jackie C, Cheung Jeanne, Rosales Rency, Kanzler Holger, Gilbert Jonathan, Hibbert Linda, Churakova Tatyana, Travis Marilyn, Vaisberg Elena, Blumenschein Wendy M, Mattson Jeanine D, Wagner Janet L, To Wayne, Zurawski Sandra, McClanahan Terrill K, Gorman Daniel M, Bazan J.Fernando, de Waal Malefyt Rene, Rennick Donna, Kastelein Robert A, IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T Cells, 10.1016/s1074-7613(02)00324-2
  2. Yoshida H., Nakaya M., Miyazaki Y., Interleukin 27: a double-edged sword for offense and defense, 10.1189/jlb.0609445
  3. Dibra D., Cutrera J. J., Li S., Coordination between TLR9 Signaling in Macrophages and CD3 Signaling in T Cells Induces Robust Expression of IL-30, 10.4049/jimmunol.1100883
  4. Lucas S., Ghilardi N., Li J., de Sauvage F. J., IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms, 10.1073/pnas.2536517100
  5. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J. F., Phillips J. H., McClanahan T. K., de Waal Malefyt R., Kastelein R. A., WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27, 10.4049/jimmunol.172.4.2225
  6. Yoshida Hiroki, Hamano Shinjiro, Senaldi Giorgio, Covey Todd, Faggioni Raffaella, Mu Sharon, Xia Min, Wakeham Andrew C, Nishina Hiroshi, Potter Julia, Saris Chris J.M, Mak Tak W, WSX-1 Is Required for the Initiation of Th1 Responses and Resistance to L. major Infection, 10.1016/s1074-7613(01)00206-0
  7. Morishima N., Owaki T., Asakawa M., Kamiya S., Mizuguchi J., Yoshimoto T., Augmentation of Effector CD8+ T Cell Generation with Enhanced Granzyme B Expression by IL-27, 10.4049/jimmunol.175.3.1686
  8. Kamiya S., Owaki T., Morishima N., Fukai F., Mizuguchi J., Yoshimoto T., An Indispensable Role for STAT1 in IL-27-Induced T-bet Expression but Not Proliferation of Naive CD4+ T Cells, 10.4049/jimmunol.173.6.3871
  9. Artis D., Villarino A., Silverman M., He W., Thornton E. M., Mu S., Summer S., Covey T. M., Huang E., Yoshida H., Koretzky G., Goldschmidt M., Wu G. D., de Sauvage F., Miller H. R. P., Saris C. J. M., Scott P., Hunter C. A., The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity, 10.4049/jimmunol.173.9.5626
  10. Stumhofer Jason S, Laurence Arian, Wilson Emma H, Huang Elaine, Tato Cristina M, Johnson Leanne M, Villarino Alejandro V, Huang Qiulong, Yoshimura Akihiko, Sehy David, Saris Christiaan J M, O'Shea John J, Hennighausen Lothar, Ernst Matthias, Hunter Christopher A, Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system, 10.1038/ni1376
  11. Uyttenhove C., Marillier R. G., Tacchini-Cottier F., Charmoy M., Caspi R. R., Damsker J. M., Goriely S., Su D., Van Damme J., Struyf S., Opdenakker G., Van Snick J., Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection, 10.1189/jlb.1210699
  12. Owaki T., Asakawa M., Morishima N., Hata K., Fukai F., Matsui M., Mizuguchi J., Yoshimoto T., A Role for IL-27 in Early Regulation of Th1 Differentiation, 10.4049/jimmunol.175.4.2191
  13. Hibbert Linda, Pflanz Stefan, de Waal Malefyt Rene, Kastelein Robert A., IL-27 and IFN-αSignal via Stat1 and Stat3 and Induce T-Bet and IL-12Rβ2 in Naive T Cells, 10.1089/10799900360708632
  14. Yoshimoto T., Yoshimoto T., Yasuda K., Mizuguchi J., Nakanishi K., IL-27 Suppresses Th2 Cell Development and Th2 Cytokines Production from Polarized Th2 Cells: A Novel Therapeutic Way for Th2-Mediated Allergic Inflammation, 10.4049/jimmunol.179.7.4415
  15. Batten Marcel, Li Ji, Yi Sothy, Kljavin Noelyn M, Danilenko Dimitry M, Lucas Sophie, Lee James, de Sauvage Frederic J, Ghilardi Nico, Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells, 10.1038/ni1375
  16. Villarino Alejandro, Hibbert Linda, Lieberman Linda, Wilson Emma, Mak Tak, Yoshida Hiroki, Kastelein Robert A., Saris Christiaan, Hunter Christopher A., The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during Infection, 10.1016/s1074-7613(03)00300-5
  17. Awasthi Amit, Carrier Yijun, Peron Jean P S, Bettelli Estelle, Kamanaka Masahito, Flavell Richard A, Kuchroo Vijay K, Oukka Mohamed, Weiner Howard L, A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells, 10.1038/ni1541
  18. Stumhofer Jason S, Silver Jonathan S, Laurence Arian, Porrett Paige M, Harris Tajie H, Turka Laurence A, Ernst Matthias, Saris Christiaan J M, O'Shea John J, Hunter Christopher A, Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10, 10.1038/ni1537
  19. Fitzgerald D. C., Ciric B., Touil T., Harle H., Grammatikopolou J., Sarma J. D., Gran B., Zhang G.-X., Rostami A., Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis, 10.4049/jimmunol.179.5.3268
  20. Batten M., Kljavin N. M., Li J., Walter M. J., de Sauvage F. J., Ghilardi N., Cutting Edge: IL-27 Is a Potent Inducer of IL-10 but Not FoxP3 in Murine T Cells, 10.4049/jimmunol.180.5.2752
  21. Pot C., Jin H., Awasthi A., Liu S. M., Lai C.-Y., Madan R., Sharpe A. H., Karp C. L., Miaw S.-C., Ho I-C., Kuchroo V. K., Cutting Edge: IL-27 Induces the Transcription Factor c-Maf, Cytokine IL-21, and the Costimulatory Receptor ICOS that Coordinately Act Together to Promote Differentiation of IL-10-Producing Tr1 Cells, 10.4049/jimmunol.0901233
  22. Tait Wojno E. D., Hosken N., Stumhofer J. S., O'Hara A. C., Mauldin E., Fang Q., Turka L. A., Levin S. D., Hunter C. A., A Role for IL-27 in Limiting T Regulatory Cell Populations, 10.4049/jimmunol.1004182
  23. Barton-Burke, Oncology, 22, 31 (2008)
  24. Deeg H. J., How I treat refractory acute GVHD, 10.1182/blood-2006-12-041889
  25. Robin Marie, Porcher Raphael, de Castro Renato, Fisher Gustavo, de Latour Régis Peffault, Ribaud Patricia, Petropoulou Anna D., Rocha Vanderson, Devergie Agnès, Mary Jean-Yves, Socié Gérard, Initial Liver Involvement in Acute GVHD is Predictive for Nonrelapse Mortality : , 10.1097/tp.0b013e3181bc2583
  26. Antin, Blood, 80, 2964 (1992)
  27. Yabe M, Yabe H, Hattori K, Shimizu T, Matsumoto M, Morimoto T, Yasuda Y, Inoue H, Kato S, Nishimura T, Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients, 10.1038/sj.bmt.1701819
  28. Di Ianni M., Falzetti F., Carotti A., Terenzi A., Castellino F., Bonifacio E., Del Papa B., Zei T., Ostini R. I., Cecchini D., Aloisi T., Perruccio K., Ruggeri L., Balucani C., Pierini A., Sportoletti P., Aristei C., Falini B., Reisner Y., Velardi A., Aversa F., Martelli M. F., Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation, 10.1182/blood-2010-10-311894
  29. Hannon, Transfusion, 2, 353 (2014)
  30. Pulaiev R., Puliaeva I., Ryan A., Via C., The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation, 10.2174/156801305774962204
  31. Via, J. Immunol., 153, 4040 (1994)
  32. Williamson, J. Immunol., 159, 1208 (1997)
  33. Shustov, J. Immunol., 161, 2848 (1998)
  34. Jassoy, J. Immunol., 149, 3113 (1992)
  35. Cox Jennifer H., Kljavin Noelyn M., Ramamoorthi Nandhini, Diehl Lauri, Batten Marcel, Ghilardi Nico, IL-27 promotes T cell–dependent colitis through multiple mechanisms, 10.1084/jem.20100410
  36. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T. W., Yoshimura A., Yoshida H., Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment, 10.4049/jimmunol.170.10.4886
  37. Rus, J. Immunol., 155, 2396 (1995)
  38. Siebler J., Wirtz S., Frenzel C., Schuchmann M., Lohse A. W., Galle P. R., Neurath M. F., Cutting Edge: A Key Pathogenic Role of IL-27 in T Cell- Mediated Hepatitis, 10.4049/jimmunol.180.1.30
  39. Ellison, J. Immunol., 161, 631 (1998)
  40. Yoshimoto T., Okada K., Morishima N., Kamiya S., Owaki T., Asakawa M., Iwakura Y., Fukai F., Mizuguchi J., Induction of IgG2a Class Switching in B Cells by IL-27, 10.4049/jimmunol.173.4.2479
  41. Ferrara James L.M., Cytokine dysregulation as a mechanism of graft versus host disease, 10.1016/0952-7915(93)90139-j
  42. Puliaev R., Nguyen P., Finkelman F. D., Via C. S., Differential Requirement for IFN-  in CTL Maturation in Acute Murine Graft-versus-Host Disease, 10.4049/jimmunol.173.2.910
  43. Puliaev R., Puliaeva I., Welniak L. A., Ryan A. E., Haas M., Murphy W. J., Via C. S., CTL-Promoting Effects of CD40 Stimulation Outweigh B Cell-Stimulatory Effects Resulting in B Cell Elimination and Disease Improvement in a Murine Model of Lupus, 10.4049/jimmunol.181.1.47
  44. Soloviova K., Puliaiev M., Haas M., Via C. S., In Vivo Maturation of Allo-Specific CD8 CTL and Prevention of Lupus-like Graft-versus-Host Disease Is Critically Dependent on T Cell Signaling through the TNF p75 Receptor But Not the TNF p55 Receptor, 10.4049/jimmunol.1300091
  45. Murphy William J., Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes, 10.1172/jci11088
  46. Shimozato Osamu, Sato Ayako, Kawamura Kiyoko, Chiyo Masako, Ma Guangyu, Li Quanhai, Tagawa Masatoshi, The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses, 10.1111/j.1365-2567.2009.03088.x
  47. Hoffmann Petra, Ermann Joerg, Edinger Matthias, Fathman C. Garrison, Strober Samuel, Donor-type CD4+CD25+Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation, 10.1084/jem.20020399
  48. Huber M., Steinwald V., Guralnik A., Brustle A., Kleemann P., Rosenplanter C., Decker T., Lohoff M., IL-27 inhibits the development of regulatory T cells via STAT3, 10.1093/intimm/dxm139
  49. Neufert Clemens, Becker Christoph, Wirtz Stefan, Fantini Massimo C., Weigmann Benno, Galle Peter R., Neurath Markus F., IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1, 10.1002/eji.200636896
  50. Stumhofer Jason S, Tait Elia D, III William J Quinn, Hosken Nancy, Spudy Björn, Goenka Radhika, Fielding Ceri A, O'Hara Aisling C, Chen Yi, Jones Michael L, Saris Christiaan J M, Rose-John Stefan, Cua Daniel J, Jones Simon A, Elloso Merle M, Grötzinger Joachim, Cancro Michael P, Levin Steven D, Hunter Christopher A, A role for IL-27p28 as an antagonist of gp130-mediated signaling, 10.1038/ni.1957
  51. Maaser Christian, Egan Laurence J., Birkenbach Mark P., Eckmann Lars, Kagnoff Martin F., Expression of Epstein-Barr virus-induced gene 3 and other interleukin-12-related molecules by human intestinal epithelium, 10.1111/j.1365-2567.2004.01895.x
  52. Crabe S., Guay-Giroux A., Tormo A. J., Duluc D., Lissilaa R., Guilhot F., Mavoungou-Bigouagou U., Lefouili F., Cognet I., Ferlin W., Elson G., Jeannin P., Gauchat J.-F., The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling, 10.4049/jimmunol.0901464
  53. Michael, Isr. Med. Assoc. J., 15, 44 (2013)
  54. Uyttenhove Catherine, Van Snick Jacques, Anti-cytokine auto-vaccinations as tools for the analysis of cytokine function in vivo, 10.1016/j.cytogfr.2011.12.001
  55. Uyttenhove Catherine, Van Snick Jacques, Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis, 10.1002/eji.200636662